Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
47.7M
-
Shares change
-
+7.07M
-
Total reported value, excl. options
-
$267M
-
Value change
-
+$32.2M
-
Put/Call ratio
-
1.26
-
Number of buys
-
64
-
Number of sells
-
-52
-
Price
-
$5.60
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q3 2018
168 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q3 2018.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.7M shares
of 159M outstanding shares and own 30% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (8.2M shares), BlackRock Inc. (4.42M shares), venBio Select Advisor LLC (4.2M shares), STATE STREET CORP (4.14M shares), Vanguard Group Inc (3.06M shares), FMR LLC (2.94M shares), BRIDGER MANAGEMENT, LLC (2.19M shares), GREAT POINT PARTNERS LLC (1.95M shares), FRANKLIN RESOURCES INC (1.89M shares), and CREDIT AGRICOLE S A (1.32M shares).
This table shows the top 120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.